Stockreport

Dova Pharmaceuticals Announces U.S. FDA Approval of DOPTELET® (avatrombopag)

DOVA PHARMACEUTICALS  (DOVA) 
Last dova pharmaceuticals earnings: 11/12 06:05 am Check Earnings Report
US:NASDAQ Investor Relations: investors.dova.com/investor-relations
PDF DURHAM, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced the U.S. Food and Drug Administration (FDA) has completed their [Read more]